You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
復星醫藥(02196.HK):持續督導保薦代表人變更為崔健民
格隆匯 12-20 17:09

格隆匯12月20日丨復星醫藥(02196.HK)公告,上海復星醫藥(集團)股份有限公司於近日收到公司保薦機構瑞銀證券有限責任公司出具的《關於更換上海復星醫藥(集團)股份有限公司非公開發行A股股票持續督導保薦代表人的函》。因瑞銀證券委派的保薦代表人張帆工作變動,作為承接本公司2010年非公開發行A股股票募集資金持續督導的保薦機構,為保障相關持續督導工作的有序進行,瑞銀證券決定由保薦代表人崔健民接替其持續督導工作,與羅勇共同履行保薦職責。

本次變更後,公司持續督導保薦代表人為瑞銀證券委派的崔健民與羅勇以及德邦證券股份有限公司委派的吳旺順與孫峯。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of this article is for reference only. It does not constitute an offer, solicitation, recommendation, opinion or guarantee of any securities, financial products or instruments.The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance.
uSMART
Wealth Growth Made Easy
Open Account